Table 1

Metalloproteinase axis mRNA expression in lymphocytic infiltrate-positive breast cancer

mRNA

Differential expression

P-value


Timp1

0.043

Timp2

NC

0.565

Timp3

1.4E-7

Timp4

0.004

RECK

1.2E-6

Mmp1

1.4E-5

Mmp2

2.8E-4

Mmp3

NC

0.54

Mmp7

2.2E-5

Mmp8

NC

0.388

Mmp9

0.009

Mmp10

NC

0.47

Mmp11

3.3E-4

Mmp12

3.5E-7

Mmp13

0.02

Mmp14

NC

0.225

Mmp15

NC

0.058

Mmp16

NC

0.416

Mmp17

NC

0.511

Mmp19

0.049

Mmp20

9.4E-4

Mmp23

8.3E-5

Mmp24

NC

0.72

Mmp25

NC

0.794

MmpL1

NC

0.794

Adam8

1.8E-4

Adam9

NC

0.574

Adam10

NC

0.25

Adam12

0.001

Adam15

NC

0.062

Adam17

0.005

Adam19

NC

0.067

Adam23

NC

0.625

Adam28

NC

0.291

Adam33

0.029

Adamts1

NC

0.068

Adamts4

NC

0.16

Adamts5

0.008


Up and down arrows indicate increased and decreased expression, respectively; NC indicates no change. ADAM, a disintegrin and a metalloproteinase; ADAMTS, ADAM with a thrombospondin domain; MMP, matrix metalloproteinase; RECK, reversion-inducing cysteine-rich protein with Kazal motifs; TIMP, tissue inhibitor of metalloproteinase.

Hojilla et al. Breast Cancer Research 2008 10:205   doi:10.1186/bcr1980